Clinical Trials in Ohio

Showing 12581-12600 of 20,938 trials

Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population

NCT03787472

The clinical study is a randomized-controlled, double-masked, crossover clinical trial with two study treatments to compare two study lens types and the initial performance, in terms of the subjective response after a period of lens dispensing. The study will last approximately 2 to 4 months.

Visual Acuity

Johnson & Johnson Vision Care, Inc.45 participantsStarted Jan 2019

Maitland, Florida, United States • Raytown, Missouri, United States • Jamestown, New York, United States +2 more locations

COMPLETEDPhase 332 miles

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

NCT03002077

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Depressive Disorder, Major

Naurex, Inc, an affiliate of Allergan plc617 participantsStarted Feb 2017

Birmingham, Alabama, United States • Dothan, Alabama, United States • Phoenix, Arizona, United States +125 more locations

Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Find Trials by Condition in Ohio

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Development and Validation of a New Digital Dermatoscope in the United States

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)